Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase 1 ...

A study shows that 18-hole rounds provide superior blood sugar and cholesterol benefits compared to walking, demonstrating ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase ...

Detailed price information for Xilio Therapeutics Inc (XLO-Q) from The Globe and Mail including charting and trades.

The Windsor-Essex Therapeutic Riding Association, or WETRA, provides therapy to 200 people with disabilities every week. We ...

Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...

Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...

Multiple Senior Vice Presidents of this biotech company recently engaged in transactions that involved thousands of shares.

In a restructured asset deal, Argent BioPharma will acquire AusCann Group’s 48% interest in CannPal Animal Therapeutics. ...

“The 4-2-3k method promotes daily movement, which is crucial for joint health, circulation and pain management,” Fulop said. ...

RevitalVision is an FDA-cleared perceptual learning software program that has been clinically validated to improve vision in several eye diseases and vision conditions--such as adult amblyopia, ...